Author:
Yonemori Kan,Katsumata Noriyuki,Noda Ayako,Uno Hajime,Yunokawa Mayu,Nakano Eriko,Kouno Tsutomu,Shimizu Chikako,Ando Masashi,Tamura Kenji,Takeuchi Masahiro,Fujiwara Yasuhiro
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference24 articles.
1. Dixon AR, Jackson L, Chan SY, Badley RA, Blamey RW (1993) Continuous chemotherapy in responsive metastatic breast cancer: a role for tumour markers? Br J Cancer 68:181–185
2. Duffy MJ (2001) Biochemical markers in breast cancer: which ones are clinically useful? Clin Biochem 34:347–352
3. Duffy MJ (2006) Serum tumor markers in breast cancer: are they of clinical value? Clin Chem 52:345–351
4. Fehm T, Jagar W, Kramer S, Sohn C, Solomayer E, Wallwiener D, Gebauer G (2004) Prognostic significance of serum HER2 and CA 15-3 at the time of diagnosis of metastatic breast cancer. Anticancer Res 24:1987–1992
5. Finek J, Holubec L Jr, Topolcan O, Elgrova L, Skalova A, Pecen L (2007) The importance of prognostic factors in premenopausal woman with breast cancer. Anticancer Res 27:1893–1896
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献